Related references
Note: Only part of the references are listed.Fenofibrate - A Potential Systemic Treatment for Diabetic Retinopathy?
Tien Yin Wong et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction
Paul M. Titchenell et al.
BIOCHEMICAL JOURNAL (2012)
Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy
Jinzi Zhou et al.
CURRENT EYE RESEARCH (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2012)
Oral Targeting of Protein Kinase C Receptor: Promising Route for Diabetic Retinopathy?
Deepa Pathak et al.
CURRENT DRUG DELIVERY (2012)
Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets
Sampathkumar Rangasamy et al.
MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY (2012)
Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation
Gerald Schmidinger et al.
ACTA OPHTHALMOLOGICA (2011)
Treatment of diabetic retinopathy with anti-VEGF drugs
Michael Waisbourd et al.
ACTA OPHTHALMOLOGICA (2011)
AGEs, RAGE, and Diabetic Retinopathy
Hongliang Zong et al.
CURRENT DIABETES REPORTS (2011)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies
A. D. Wright et al.
EYE (2011)
Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes
Sul Gee Lee et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Increased Expression of Periostin in Vitreous and Fibrovascular Membranes Obtained from Patients with Proliferative Diabetic Retinopathy
Shigeo Yoshida et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
A review of clinical trials of anti-VEGF agents for diabetic retinopathy
Benjamin P. Nicholson et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
Emily Y. Chew et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Suppression of ICAM-1 in Retinal and Choroidal Endothelial Cells by Plasmid Small-Interfering RNAs In Vivo
Yoshio Hirano et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
Ryoichi Arita et al.
DIABETES (2009)
Proliferative diabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system
Joanna Adamiec-Mroczek et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial
J. W. J. Beulens et al.
DIABETOLOGIA (2009)
Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy
Pedro Geraldes et al.
NATURE MEDICINE (2009)
Protective Effects of a Coumarin Derivative in Diabetic Rats
Claudio Bucolo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Rubosixtaurin and other pkc Inhibitors in Diabetic Retinopathy and Macular Edema. Review
M. Isabel Lopez Galvez
CURRENT DIABETES REVIEWS (2009)
Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy
Joanna Adamiec-Mroczek et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus
J. N. Nicoletti et al.
NEUROSCIENCE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Immunological mechanisms in the pathogenesis of diahetic retinopathy
Anthony P. Adamis et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
Deepti Navaratna et al.
DIABETES (2007)
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury
Kazuaki Nishijima et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy
Prema Abraham et al.
OPHTHALMOLOGY (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
RL Avery et al.
OPHTHALMOLOGY (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
The role of AGEs and AGE inhibitors in diabetic cardiovascular disease
MC Thomas et al.
CURRENT DRUG TARGETS (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier
SJ Giebel et al.
LABORATORY INVESTIGATION (2005)
Angiopoietin concentrations in diabetic retinopathy
JI Patel et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
VEGF164(165) as the pathological isoform:: Differential leukocyte and endothelial responses through VEGFR1 and VEGFR2
T Usui et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Matrix metalloproteinases as modulators of inflammation and innate immunity
WC Parks et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy
A Tashimo et al.
DIABETIC MEDICINE (2004)
A central role for inflammation in the pathogenesis of diabetic retinopathy
AM Joussen et al.
FASEB JOURNAL (2004)
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
YJ Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The potential role of PKC β in diabetic retinopathy and macular edema
LP Aiello
SURVEY OF OPHTHALMOLOGY (2002)
Potential new medical therapies for diabetic retinopathy: Protein kinase C inhibitors
RN Frank
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo
AM Joussen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate
MJ Tolentino et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy
T Yuuki et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2001)
Matrix metalloproteinases in human diabetic and nondiabetic vitreous
M Jin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2001)
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats
S Cuzzocrea et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain
ZG Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
